3/9
02:46 pm
dyn
Dyne Therapeutics (DYN) had its "buy" rating reaffirmed by Chardan Capital. They now have a $38.00 price target on the stock.
Low
Report
Dyne Therapeutics (DYN) had its "buy" rating reaffirmed by Chardan Capital. They now have a $38.00 price target on the stock.
3/9
02:10 pm
dyn
Rating for DYN
Medium
Report
Rating for DYN
3/3
11:43 am
dyn
Rating for DYN
Medium
Report
Rating for DYN
3/3
11:43 am
dyn
Rating for DYN
Medium
Report
Rating for DYN
3/3
07:38 am
dyn
Rating for DYN
Medium
Report
Rating for DYN
3/2
01:05 pm
dyn
Dyne Therapeutics (DYN) had its "overweight" rating reaffirmed by Morgan Stanley.
Low
Report
Dyne Therapeutics (DYN) had its "overweight" rating reaffirmed by Morgan Stanley.
3/2
01:05 pm
dyn
Dyne Therapeutics (DYN) had its "overweight" rating reaffirmed by Morgan Stanley.
Low
Report
Dyne Therapeutics (DYN) had its "overweight" rating reaffirmed by Morgan Stanley.
1/20
10:14 am
dyn
Rating for DYN
Low
Report
Rating for DYN